APA

Ryan C., Sobell J. M., Leonardi C. L., Lynde C. W., Karunaratne M., Valdecantos W. C. & Hendrickson B. A. (20181001). Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis. : American journal of clinical dermatology.

Chicago

Ryan Caitriona, Sobell Jeffrey M, Leonardi Craig L, Lynde Charles W, Karunaratne Mahinda, Valdecantos Wendell C and Hendrickson Barbara A. 20181001. Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis. : American journal of clinical dermatology.

Harvard

Ryan C., Sobell J. M., Leonardi C. L., Lynde C. W., Karunaratne M., Valdecantos W. C. and Hendrickson B. A. (20181001). Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis. : American journal of clinical dermatology.

MLA

Ryan Caitriona, Sobell Jeffrey M, Leonardi Craig L, Lynde Charles W, Karunaratne Mahinda, Valdecantos Wendell C and Hendrickson Barbara A. Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis. : American journal of clinical dermatology. 20181001.